I was fortunate enough to be part of the #DAPeoplesVoice for 2019, this means DA organises a media pass for us to attend the Australian Diabetes Congress, as it’s in my home town this year, I’m organising my own transport and accommodation.
I know everyone’s always eager to hear about new tech, so the big announcement is the launch of the Solo Pump from Roche. Here’s what I know so far:
It’s a pump patch and it’s much smaller than either the Omnipod or the Cellnovo (neither of which are available in Australia as of today’s date).
Before you get too excited the Solo isn’t available in Australia yet either, it isn’t listed on the TGA yet and negotiations re the funding model aren’t complete yet either. The Roche rep I spoke to indicated they are very hopeful of a November TGA listing.
The pump detaches from the body easily, leaving a pump holder attached to the skin.
The pump is quite different from the ones we’re currently used to in terms of its pump and consumables set-up and so the funding model will be different too. The shelf life of the different components varies, as I understand it the pump life is 1 year, therefore, your PHI would be paying approximately $2k/year rather than the $7-10k every 4 to 5 years.
Downsides it seems to me is that the battery and reservoir are one item and the battery ‘dies’ after 4 days, so I don’t think you can extend the life of the reservoir. I tend to reuse reservoirs a lot a habit I picked up before these consumables were on the NDSS, so I wouldn’t like being restricted to forced replacement every 4 days.
You must use the inserter to insert the pump-I rather like the fact that the Medtronic sets don’t need an inserter. An inserter is another bit of kit you have to carry around.
You can do a basic bolus with buttons on the actual pump, but mainly you need to carry the Roche meter & remote control to control the pump-again this is all extra kit, but given most of use don’t travel without a glucometer then it’s probably not that big a deal.
The pump doesn’t talk to any CGM and unlike, say Ypsomed who indicate they are in discussions to try to get this functionality, Roche give no indication that this is likely.
I know some people really dislike the notion of pumps with tubing, for them I suspect the Solo will be a really exciting addition to the choices we have available for pumping in Australia.
As you may be aware, this product has been developed by Eli Lilly and is being sold in the US. This really IS a gamechanger, in my opinion for people with hypo unawareness, particularly for children at school. Administration of Glucogen via injection has been really, really difficult to implement for first aid officers/teachers etc. This seems like such a great solution. It will not be available in Australia until mid-2020, it is hoped that it could be sold over the counter, at a price comparable to the current product. I not
Stay tuned for more info, I’m totally fascinated by findings around diet and the gut microbiome-seriously it’s exciting, huge potential to overthrow everything we ‘know’ about diet. Tomorrow there’s a session on gut microbiome and type 1 diabetes, I’ve heard it’s linked with the autoimmune response.
We’re still struggling with language around ‘compliance’ at conferences, trying to feel our way between inclusion and tokenism and advocate for our voices to be heard. Then there’s a thing called “The Big Drop” a hypo simulator. The softies at the stand had gone home by the time I made a beeline to investigate the trivialisation of hypoglycemia but there’s always tomorrow…
Lots more interesting stuff, including some really revolutionary stuff on diet coming soon.